Cargando…

Scotoma analysis of 10–2 visual field testing with a red target in screening for hydroxychloroquine retinopathy

OBJECTIVE: To quantify the variability of scotomas detected by 10–2 visual field (VF) testing with a red target in patients taking hydroxychloroquine without and with retinopathy. DESIGN: Retrospective review of clinical charts and VFs. METHODS: Twenty-four patients taking hydroxychloroquine without...

Descripción completa

Detalles Bibliográficos
Autores principales: Browning, David J, Lee, Chong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548756/
https://www.ncbi.nlm.nih.gov/pubmed/26316692
http://dx.doi.org/10.2147/OPTH.S87850
_version_ 1782387229288562688
author Browning, David J
Lee, Chong
author_facet Browning, David J
Lee, Chong
author_sort Browning, David J
collection PubMed
description OBJECTIVE: To quantify the variability of scotomas detected by 10–2 visual field (VF) testing with a red target in patients taking hydroxychloroquine without and with retinopathy. DESIGN: Retrospective review of clinical charts and VFs. METHODS: Twenty-four patients taking hydroxychloroquine without retinopathy, and eight patients taking hydroxychloroquine with retinopathy were tested in this study. Retinopathy was defined by annular scotomas on 10–2 VF testing with corroborative spectral domain optical coherence tomographic outer retinal changes and multifocal electroretinographic changes leading to cessation of hydroxychloroquine or chloroquine. Location and depth of scotoma points on 10–2 VF testing were recorded and their fates followed in serial, reliable 10–2 VFs performed with a red target over time. The main outcome measures for this study were the number of scotoma points and locations, percentage of persistent scotoma points, size of scotomas, location of scotomas, and percentage of scotomas deepening. RESULTS: A median of 3, interquartile range (IQR) (2, 5), scotoma points per VF occurred in patients without retinopathy. A median of 86%, IQR (77, 100), of these resolved on the subsequent field. For patients with retinopathy, a median of 50%, IQR (46, 79), resolved, a difference compared to patients without retinopathy that was significant (P=0.0158). The median percentage of scotoma points in the zone from 2° to 8° from fixation in eyes with retinopathy was 72%, IQR (54, 100), compared to 49%, IQR (40, 54), in eyes without retinopathy (P=0.0069). The number of persistent scotoma locations at the last visit was higher in eyes with retinopathy: 3, IQR (1, 3), versus 0, IQR (0, 1), in patients without retinopathy, P=0.0156. CONCLUSION: Point scotomas are common and variable in 10–2 VF testing with a red target for hydroxychloroquine retinopathy in subjects without retinopathy. Scotoma points in eyes with retinopathy are less variable. The annular zone 2°–8° from fixation was useful for distinguishing the significance of scotoma points. Discriminating eyes with retinopathy from eyes without retinopathy is probably easier using the 10–2 VF with a white target than a red target.
format Online
Article
Text
id pubmed-4548756
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-45487562015-08-27 Scotoma analysis of 10–2 visual field testing with a red target in screening for hydroxychloroquine retinopathy Browning, David J Lee, Chong Clin Ophthalmol Original Research OBJECTIVE: To quantify the variability of scotomas detected by 10–2 visual field (VF) testing with a red target in patients taking hydroxychloroquine without and with retinopathy. DESIGN: Retrospective review of clinical charts and VFs. METHODS: Twenty-four patients taking hydroxychloroquine without retinopathy, and eight patients taking hydroxychloroquine with retinopathy were tested in this study. Retinopathy was defined by annular scotomas on 10–2 VF testing with corroborative spectral domain optical coherence tomographic outer retinal changes and multifocal electroretinographic changes leading to cessation of hydroxychloroquine or chloroquine. Location and depth of scotoma points on 10–2 VF testing were recorded and their fates followed in serial, reliable 10–2 VFs performed with a red target over time. The main outcome measures for this study were the number of scotoma points and locations, percentage of persistent scotoma points, size of scotomas, location of scotomas, and percentage of scotomas deepening. RESULTS: A median of 3, interquartile range (IQR) (2, 5), scotoma points per VF occurred in patients without retinopathy. A median of 86%, IQR (77, 100), of these resolved on the subsequent field. For patients with retinopathy, a median of 50%, IQR (46, 79), resolved, a difference compared to patients without retinopathy that was significant (P=0.0158). The median percentage of scotoma points in the zone from 2° to 8° from fixation in eyes with retinopathy was 72%, IQR (54, 100), compared to 49%, IQR (40, 54), in eyes without retinopathy (P=0.0069). The number of persistent scotoma locations at the last visit was higher in eyes with retinopathy: 3, IQR (1, 3), versus 0, IQR (0, 1), in patients without retinopathy, P=0.0156. CONCLUSION: Point scotomas are common and variable in 10–2 VF testing with a red target for hydroxychloroquine retinopathy in subjects without retinopathy. Scotoma points in eyes with retinopathy are less variable. The annular zone 2°–8° from fixation was useful for distinguishing the significance of scotoma points. Discriminating eyes with retinopathy from eyes without retinopathy is probably easier using the 10–2 VF with a white target than a red target. Dove Medical Press 2015-08-20 /pmc/articles/PMC4548756/ /pubmed/26316692 http://dx.doi.org/10.2147/OPTH.S87850 Text en © 2015 Browning and Lee. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Browning, David J
Lee, Chong
Scotoma analysis of 10–2 visual field testing with a red target in screening for hydroxychloroquine retinopathy
title Scotoma analysis of 10–2 visual field testing with a red target in screening for hydroxychloroquine retinopathy
title_full Scotoma analysis of 10–2 visual field testing with a red target in screening for hydroxychloroquine retinopathy
title_fullStr Scotoma analysis of 10–2 visual field testing with a red target in screening for hydroxychloroquine retinopathy
title_full_unstemmed Scotoma analysis of 10–2 visual field testing with a red target in screening for hydroxychloroquine retinopathy
title_short Scotoma analysis of 10–2 visual field testing with a red target in screening for hydroxychloroquine retinopathy
title_sort scotoma analysis of 10–2 visual field testing with a red target in screening for hydroxychloroquine retinopathy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548756/
https://www.ncbi.nlm.nih.gov/pubmed/26316692
http://dx.doi.org/10.2147/OPTH.S87850
work_keys_str_mv AT browningdavidj scotomaanalysisof102visualfieldtestingwitharedtargetinscreeningforhydroxychloroquineretinopathy
AT leechong scotomaanalysisof102visualfieldtestingwitharedtargetinscreeningforhydroxychloroquineretinopathy